首页> 外文OA文献 >LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer

【2h】

LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer

机译：LNCRNA pCIR是一种致癌钳，通过增强Tab3和PABPC4在三阴性乳腺癌中的结合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wenhui Guo; Jingyi Li; Haobo Huang; Fangmeng Fu; Yuxiang Lin; Chuan Wang;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy [J] . Vaidya Amita M., Sun Zhanhu, Ayat Nadia, Bioconjugate Chemistry . 2019,第3期

机译：针对致癌的LNCRNA的肿瘤靶向siRNA纳米颗粒的全身递送促进了有效的三阴性乳腺癌治疗
2. Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer [J] . Giada Zurlo, Xijuan Liu, Mamoru Takada, Nature Communications . 2019,第1期

机译：脯氨酰羟化酶底座腺苷催化酶是三重阴性乳腺癌中的致癌钳
3. PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple-Negative Breast Cancer Sensitive to a gamma-Secretase Inhibitor [J] . Wang Kai, Zhang Qin, Li Danan, Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第6期

机译：缺口受体中的PEST域突变包括对γ-分泌酶抑制剂敏感的三阴性乳腺癌中的致癌驱动片段。
4. Nanoparticles Coated with Frizzled7 Antibodies Enable Multivalent Binding for Enhanced Wnt Signaling Inhibition in Triple-Negative Breast Cancer [C] . Rachel S. Riley, Emily S. Day Society for Biomaterials annual meeting and exposition . 2018

机译：纳米颗粒涂有Frizzled7抗体使三价乳腺癌中增强Wnt信号抑制的多价结合。
5. Network Analysis Identifies Driver Genes Associated with Triple Negative Breast Cancer Patient Survival [D] . Dill, Courtney Denise. 2021

机译：网络分析识别与三重阴性乳腺癌患者生存相关的司机基因
6. Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers [O] . Hamid H. Gari, Christy M. Gearheart, Susan Fosmire, 2016

机译：使用抗癌剂AMPI-109进行全基因组功能遗传筛查可确定PRL-3是三阴性乳腺癌的致癌驱动因素
7. Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers [O] . Hamid H. Gari, Christy M. Gearheart, Susan Fosmire, 2016

机译：具有抗癌剂AMPI-109的基因组功能遗传筛网将PRL-3鉴定为三阴性乳腺癌中的致癌钳
8. Cotargeting the lncRNA-PIP3 Interaction and AKT/PI3K Signaling Axis: A Novel Paradigm for Treating Triple-Negative Breast Cancer. [R] . Yang, L. 2017

机译：共定位lncRNa-pIp3相互作用和aKT / pI3K信号轴：一种治疗三阴性乳腺癌的新范式。

LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅